✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Omkar Pharmachem Ltd.

OMKARPH

Market Cap
₹30 Cr.
P/E
160.93

Omkar Pharmachem Ltd.

  • Omkar Pharmachem
  • Veerhealth Care
  • Guj. Inject (Kerala)
FAQs on Omkar Pharmachem Ltd. Shareprice

Omkar Pharmachem has given lower returns compared to its competitors.
Omkar Pharmachem has grown at ~12.04% over the last 2yrs while peers have grown at a median rate of 19.92%

Yes, Omkar Pharmachem is expensive.
Latest PE of Omkar Pharmachem is 160, while 3 year average PE is 123.
Also latest EV/EBITDA of Omkar Pharmachem is 101 while 3yr average is 82.14.

View FAQ's On Business
Growth Table
  • Omkar Pharmachem Ltd.
  • Veerhealth Care
  • Guj. Inject (Kerala)
Balance Sheet
  • Omkar Pharmachem Ltd.
  • Veerhealth Care
  • Guj. Inject (Kerala)
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Omkar Pharmachem Ltd.
  • Veerhealth Care
  • Guj. Inject (Kerala)
Cash Flow
  • Omkar Pharmachem Ltd.
  • Veerhealth Care
  • Guj. Inject (Kerala)
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Omkar Pharmachem Ltd.
  • Veerhealth Care
  • Guj. Inject (Kerala)
Quarterly Results
  • Omkar Pharmachem Ltd.
  • Veerhealth Care
  • Guj. Inject (Kerala)
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Omkar Pharmachem Ltd. Financials

Balance sheet of Omkar Pharmachem is strong.
But short term working capital might become an issue for this company.

The debt of Omkar Pharmachem is decreasing.
Latest debt of Omkar Pharmachem is ₹0.12 Crs as of Sep-24.
This is less than Mar-24 when it was ₹0.16 Crs.

The profit is oscillating.
The profit of Omkar Pharmachem is ₹0.19 Crs for Mar 2024, ₹0.2 Crs for Mar 2023 and ₹0.18 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Omkar Pharmachem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech